Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/2000
01/06/2000CA2301024A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes
01/05/2000EP0969092A1 Rice gene resistant to blast disease
01/05/2000EP0969091A2 Leptin receptor gene-related protein
01/05/2000EP0969018A1 Anti bacterial monoclonal antibodies
01/05/2000EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor
01/05/2000EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments
01/05/2000EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
01/05/2000EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies
01/05/2000EP0968289A1 Icam-6 materials and methods
01/05/2000EP0968288A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a
01/05/2000EP0968286A1 Growth factor receptor binding protein
01/05/2000EP0968285A1 Morphogenic proteins
01/05/2000EP0968276A1 NOVEL clpL
01/05/2000EP0968230A1 Oxidized fragments of apolipoprotein b and their use
01/05/2000EP0968229A1 Antigenic peptides reacting with anti-ovary antibodies
01/05/2000EP0968225A1 NOVEL spsB
01/05/2000EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
01/05/2000EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
01/05/2000EP0967995A1 Composition comprising immunoglobulin
01/05/2000EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders
01/05/2000EP0967993A2 Anti-cocaine vaccine
01/05/2000EP0967992A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque
01/05/2000EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS
01/05/2000EP0967878A1 Targeted cytotoxic cells
01/05/2000EP0859791A4 Methods for detection of cryptosporidium oocysts
01/05/2000EP0851912A4 Novel factors which modify gene transcription and methods of use therefor
01/05/2000EP0721469B1 Anti-gp39 antibodies and uses therefor
01/05/2000DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein
01/04/2000US6011139 Polypeptides
01/04/2000US6011138 Gamma-1 anti-human CD23 monoclonal antibodies
01/04/2000US6011137 Fusion proteins
01/04/2000US6011009 Method for determining angiogenesis using scatter factor
01/04/2000US6011002 Circularly permuted ligands and circularly permuted chimeric molecules
01/04/2000US6010913 Isolated human tau peptide
01/04/2000US6010903 Anti-human ceruloplasmin monoclonal antibody
01/04/2000US6010902 Complex useful in controlling lymphocytes
01/04/2000US6010897 Expression of signal-peptide-free staphylokinases
01/04/2000US6010886 Receptor for oncostatin M
01/04/2000US6010884 Recombinant binding proteins and peptides
01/04/2000US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides
01/04/2000US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6
01/04/2000US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor
01/04/2000US6010874 Early onset alzheimer's disease gene and gene products
01/04/2000US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides
01/04/2000US6010865 Process for detecting a variant CD44 gene product
01/04/2000US6010864 Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof
01/04/2000US6010862 Methods of detecting collagen type III degradation in vivo
01/04/2000US6010861 Target specific screens and their use for discovering small organic molecular pharmacophores
01/04/2000US6010855 Desaturase antigen of mycobacterium tuberculosis
01/04/2000US6010845 Leukocyte adhesion assay
01/04/2000US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them
01/04/2000US6010696 Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
01/04/2000US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
01/04/2000CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides
01/04/2000CA1340869C T cell activation markers
12/1999
12/30/1999DE19828466A1 Suppressor peptides derived from antibodies for use in immunoassays
12/30/1999DE19828377A1 A transgenic non-human mammal expressing immunoglobulin E heavy chain, useful for testing of anti-human IgE antibodies
12/30/1999CA2244211A1 Novel compounds
12/29/1999WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof
12/29/1999WO1999067391A1 Origin of replication and methods of use
12/29/1999WO1999067384A2 Prostate cancer-associated genes
12/29/1999WO1999067377A1 Human arf-related proteins
12/29/1999WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/29/1999WO1999067293A1 Peptide composition as immunogen for the treatment of allergy
12/29/1999WO1999067285A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
12/29/1999WO1999067282A2 Olfactory receptors and their uses
12/29/1999WO1999067269A1 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof
12/29/1999WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
12/29/1999WO1999066956A1 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP)
12/29/1999WO1999066955A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant
12/29/1999WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999WO1999060133A3 Human nucleic acid methylases
12/29/1999WO1999058681A3 Transgenic plant cells expressing a recombinant plant e2f peptide
12/29/1999WO1999058563A3 Moraxella catharralis proteins
12/29/1999WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor
12/29/1999WO1998055150A8 Txu-7-pap immunotoxin and use thereof
12/29/1999WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein
12/29/1999EP0967284A1 Phosphodiesterases
12/29/1999EP0967278A2 Flowering regulating gene and its use
12/29/1999EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
12/29/1999EP0966971A1 Cerebral stroke/cerebral edema preventive or remedy containing il-8 binding inhibitor as active ingredient
12/29/1999EP0966970A1 Antigen specific to meniere's disease and medical use thereof
12/29/1999EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD
12/29/1999EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/29/1999EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii)
12/29/1999EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
12/29/1999EP0966485A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
12/29/1999EP0966484A1 Neurotactin and uses therefor
12/29/1999EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds
12/29/1999EP0966300A1 Treatment of autoimmune diseases, including aids
12/29/1999EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
12/29/1999EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
12/29/1999EP0614372B1 Antiviral factor from cd8+ cells
12/29/1999EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999EP0437547B1 Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family
12/29/1999CN1240028A Assay for detection of antibodies against P53
12/29/1999CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods